The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

April 22, 2009

Conditions
Mild to Severe Alzheimer's Disease
Interventions
DRUG

Donepezil HCl

One 5 mg tablet per day (for the first 6 weeks) with a full glass of water. For the last 6 weeks, one 10mg tablet per day with a full glass of water.

Trial Locations (36)

12208

Neurological Associates of Albany, PC, Albany

14215

University Of Buffalo, Buffalo

14620

University of Rochester, Monroe Community Hospital, Rochester

19104

University of Pennsylvania, Section of Geriatric Psychiatry, Philadelphia

32833

Universal Clinical research and Technology, Orlando

33166

Galiz Research, Miami Springs

33176

Neuroscience Consultants, Miami

33613

Byrd's Alzheimer Institute, Tampa

Stedman Clinical Trials, LLC, Tampa

34285

Center for Clinical Trials, Venice

35209

Senior Care, Birmingham

38204

South Coast Clinical Trials, Anaheim

42003

Four Rivers Clinical Research, Paducah

45959

Valley Medical Research, Centerville

46260

Agewell Health Ltd, Indianapolis

60007

Alexian Brothers Neuroscience Institute, Elk Grove

66202

Venture Resource Group Inc, Mission

73103

Infinity Research Group, Oklahoma City

75024

Mech Center, Plano

78757

Senior Adults Specialty Research, Austin

85004

21st Century Neurology, Phoenix

85050

Psypharma Clinical Research, Phoenix

87131

University of New Mexico, Albuquerque

89102

Horne Research, Las Vegas

90250

Sarah Sam Olelewe, MD Inc, Hawthorne

90746

AVI Clinical Research, Carson

92701

Neuropsychiatric Research Center of Orange County, Santa Ana

92804

Rush Alzheimer Disease Center, Chicago

93720

Margolin Brain Institute, Fresno

06810

Danbury Clinical Research, LLC, Danbury

06851

Research Center for Clinical Studies, Norwalk

02478

McLean Hospital Geriatric Psychiatry, Belmont

01201

Neuroscience Research of the Bershires, Pittsfield

08755

Bio Behavioral Health, Toms River

02914

Rhode Island Mood and Memory Research Institute, East Providence

02916

CNS Research, INC, East Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT00571064 - The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility | Biotech Hunter | Biotech Hunter